Sapara Corporation is a company that conducts contract research, contract production, and contract analysis of organic materials.
Sapara Corporation is a company based in Hyderabad, India, that conducts contract research, contract manufacturing, and contract analysis of organic substances. The region of Hyderabad is very famous for IT-related activities, but it is also a vibrant area for research and development in the field of pharmaceuticals. Sapara Corporation has strengths in research and development of specialized organic compounds, process design, and analysis, and has received patronage from major countries around the world, including not only Japan but also Europe and the United States. Recently, we have achieved notable results in the field of research and development related to nucleic acid pharmaceuticals. Additionally, our founder has over 20 years of work experience in Japan and is fluent in the language, so we are confident that we can deliver results that will satisfy our Japanese clients. By the way, the name "Sapara" is derived from the initials of the three goddesses of India. *You can download the English version of our catalog. *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
*You can download the English version of the catalog. *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
*You can download the English version of the catalog. *For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Ayurveda is well-known, but historically, India has been significantly involved with "medicine." Sapala Organics was established in 2005 in Hyderabad, located in the central part of the Deccan Plateau. The state government is actively investing to make this area a "Pharma City" (a treasure trove of medicine). Sapala has gained recognition from major pharmaceutical companies in the United States and Europe, steadily achieving results. To further provide the technological capabilities developed globally to Japan, Sapala Corporation was established in February 2018 as a local subsidiary in Japan. Recently, the Japanese government has also been focusing on projects that promote advanced pharmaceutical development and drug discovery, including nucleic acid-related drugs. We encourage you to consider the technological expertise of "Sapala," which excels in these fields.
![[Research Material] The Global Market for Difluoroacetic Acid](https://image.mono.ipros.com/public/product/image/b86/2001480993/IPROS80328444285000426932.jpeg?w=280&h=280)
![[Research Material] The Global Market for Octanohydroxamic Acid](https://image.mono.ipros.com/public/product/image/5e0/2001467302/IPROS91271143337187604680.jpeg?w=280&h=280)
